

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of interleukin-12 production (GO:0032695) | 4.44266235 |
| 2 | macrophage activation involved in immune response (GO:0002281) | 4.40095206 |
| 3 | detection of molecule of bacterial origin (GO:0032490) | 4.35129396 |
| 4 | interferon-gamma-mediated signaling pathway (GO:0060333) | 4.18154427 |
| 5 | hepatocyte apoptotic process (GO:0097284) | 4.15955725 |
| 6 | response to peptidoglycan (GO:0032494) | 3.90978108 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.80859362 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.80859362 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.69129878 |
| 10 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.67335627 |
| 11 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.59792433 |
| 12 | cellular response to interferon-alpha (GO:0035457) | 3.57191779 |
| 13 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.55864338 |
| 14 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.50956480 |
| 15 | cellular response to interferon-gamma (GO:0071346) | 3.41123529 |
| 16 | detection of biotic stimulus (GO:0009595) | 3.39913001 |
| 17 | response to interferon-gamma (GO:0034341) | 3.36869941 |
| 18 | response to host immune response (GO:0052572) | 3.33591983 |
| 19 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.33591983 |
| 20 | * response to interferon-beta (GO:0035456) | 3.31419159 |
| 21 | response to nitrosative stress (GO:0051409) | 3.28000932 |
| 22 | myeloid cell activation involved in immune response (GO:0002275) | 3.26121407 |
| 23 | microglial cell activation (GO:0001774) | 3.23382187 |
| 24 | negative regulation of cell killing (GO:0031342) | 3.22242918 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.22242918 |
| 26 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.19134943 |
| 27 | regulation of antigen processing and presentation (GO:0002577) | 3.18966389 |
| 28 | positive regulation of antigen processing and presentation (GO:0002579) | 3.16130949 |
| 29 | macrophage activation (GO:0042116) | 3.13670453 |
| 30 | * defense response to virus (GO:0051607) | 3.12209576 |
| 31 | neutrophil activation involved in immune response (GO:0002283) | 3.10206797 |
| 32 | response to host (GO:0075136) | 3.07845731 |
| 33 | response to host defenses (GO:0052200) | 3.07845731 |
| 34 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.07845731 |
| 35 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.07332780 |
| 36 | * regulation of viral genome replication (GO:0045069) | 3.05210988 |
| 37 | regulation of RIG-I signaling pathway (GO:0039535) | 3.04789790 |
| 38 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.03795682 |
| 39 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.01566362 |
| 40 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.99822107 |
| 41 | detection of other organism (GO:0098543) | 2.98748134 |
| 42 | cellular response to interferon-beta (GO:0035458) | 2.98088030 |
| 43 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.97851915 |
| 44 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.94898909 |
| 45 | lymphocyte chemotaxis (GO:0048247) | 2.94501208 |
| 46 | positive regulation of interferon-alpha production (GO:0032727) | 2.93951568 |
| 47 | regulation of type 2 immune response (GO:0002828) | 2.90721713 |
| 48 | NIK/NF-kappaB signaling (GO:0038061) | 2.90655629 |
| 49 | ribosomal small subunit assembly (GO:0000028) | 2.87407345 |
| 50 | regulation of T cell tolerance induction (GO:0002664) | 2.87124955 |
| 51 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.87108807 |
| 52 | cellular extravasation (GO:0045123) | 2.87042316 |
| 53 | regulation of tolerance induction (GO:0002643) | 2.85892613 |
| 54 | regulation of interferon-beta production (GO:0032648) | 2.84975040 |
| 55 | xenobiotic catabolic process (GO:0042178) | 2.84614938 |
| 56 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.83708989 |
| 57 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.82522028 |
| 58 | regulation of immunoglobulin secretion (GO:0051023) | 2.80893825 |
| 59 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.80779480 |
| 60 | regulation of vitamin metabolic process (GO:0030656) | 2.80205011 |
| 61 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.78420663 |
| 62 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.77799082 |
| 63 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.76721270 |
| 64 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.76715243 |
| 65 | regulation of interferon-alpha production (GO:0032647) | 2.76493575 |
| 66 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.76441940 |
| 67 | * negative regulation of viral process (GO:0048525) | 2.76292125 |
| 68 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.75354259 |
| 69 | regulation of activation of Janus kinase activity (GO:0010533) | 2.74979144 |
| 70 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.74672169 |
| 71 | regulation of interleukin-12 production (GO:0032655) | 2.74500203 |
| 72 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.73539698 |
| 73 | response to type I interferon (GO:0034340) | 2.73252113 |
| 74 | response to protozoan (GO:0001562) | 2.71726620 |
| 75 | positive regulation of interleukin-6 production (GO:0032755) | 2.70969192 |
| 76 | cellular response to type I interferon (GO:0071357) | 2.70762904 |
| 77 | type I interferon signaling pathway (GO:0060337) | 2.70762904 |
| 78 | positive regulation of acute inflammatory response (GO:0002675) | 2.70469176 |
| 79 | T cell migration (GO:0072678) | 2.70286689 |
| 80 | germinal center formation (GO:0002467) | 2.70061086 |
| 81 | positive regulation of chemokine production (GO:0032722) | 2.69441926 |
| 82 | thrombin receptor signaling pathway (GO:0070493) | 2.68986952 |
| 83 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.68982001 |
| 84 | regulation of growth of symbiont in host (GO:0044126) | 2.68982001 |
| 85 | negative regulation of growth of symbiont in host (GO:0044130) | 2.68982001 |
| 86 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.68982001 |
| 87 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.68737246 |
| 88 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.67346553 |
| 89 | production of molecular mediator of immune response (GO:0002440) | 2.65369407 |
| 90 | detection of bacterium (GO:0016045) | 2.64748113 |
| 91 | regulation of chemokine biosynthetic process (GO:0045073) | 2.63557480 |
| 92 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.59369646 |
| 93 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 2.58562466 |
| 94 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 2.58562466 |
| 95 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.58439365 |
| 96 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.56039106 |
| 97 | regulation of podosome assembly (GO:0071801) | 2.53343099 |
| 98 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.53305933 |
| 99 | natural killer cell mediated immunity (GO:0002228) | 2.51966843 |
| 100 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.51966843 |
| 101 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.51669775 |
| 102 | response to interferon-alpha (GO:0035455) | 2.50500774 |
| 103 | negative regulation of lipid storage (GO:0010888) | 2.50172817 |
| 104 | regulation of natural killer cell differentiation (GO:0032823) | 2.49256785 |
| 105 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.49010291 |
| 106 | positive regulation of interleukin-12 production (GO:0032735) | 2.48798346 |
| 107 | * negative regulation of viral genome replication (GO:0045071) | 2.48530156 |
| 108 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.48376858 |
| 109 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.46622948 |
| 110 | myeloid dendritic cell differentiation (GO:0043011) | 2.46505379 |
| 111 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.45150325 |
| 112 | natural killer cell activation involved in immune response (GO:0002323) | 2.45028426 |
| 113 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.44520264 |
| 114 | defense response to protozoan (GO:0042832) | 2.43596106 |
| 115 | cellular response to exogenous dsRNA (GO:0071360) | 2.42449387 |
| 116 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 2.41402088 |
| 117 | positive regulation of humoral immune response (GO:0002922) | 2.40512608 |
| 118 | immunoglobulin mediated immune response (GO:0016064) | 2.39789837 |
| 119 | interferon-gamma secretion (GO:0072643) | 2.39195270 |
| 120 | regulation of T-helper cell differentiation (GO:0045622) | 2.37927888 |
| 121 | positive regulation of interferon-beta production (GO:0032728) | 2.37225070 |
| 122 | positive regulation of interleukin-17 production (GO:0032740) | 2.35983537 |
| 123 | myeloid dendritic cell activation (GO:0001773) | 2.35614543 |
| 124 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.30335382 |
| 125 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.27509203 |
| 126 | response to muramyl dipeptide (GO:0032495) | 2.26812697 |
| 127 | leukocyte apoptotic process (GO:0071887) | 2.26734436 |
| 128 | positive regulation of type 2 immune response (GO:0002830) | 2.26268439 |
| 129 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.25958084 |
| 130 | positive regulation of B cell mediated immunity (GO:0002714) | 2.24558371 |
| 131 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.24558371 |
| 132 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.23797406 |
| 133 | positive regulation of defense response to virus by host (GO:0002230) | 2.23261045 |
| 134 | granulocyte activation (GO:0036230) | 2.22653719 |
| 135 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.22532034 |
| 136 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.22531565 |
| 137 | T cell apoptotic process (GO:0070231) | 2.21296978 |
| 138 | neutrophil activation (GO:0042119) | 2.20937116 |
| 139 | B cell mediated immunity (GO:0019724) | 2.20822651 |
| 140 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.17918160 |
| 141 | regulation of memory T cell differentiation (GO:0043380) | 2.17634646 |
| 142 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.16746880 |
| 143 | cell adhesion mediated by integrin (GO:0033627) | 2.16670291 |
| 144 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.16226121 |
| 145 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.16226121 |
| 146 | modulation by symbiont of host immune response (GO:0052553) | 2.16226121 |
| 147 | positive regulation by symbiont of host defense response (GO:0052509) | 2.16226121 |
| 148 | modulation by symbiont of host defense response (GO:0052031) | 2.16226121 |
| 149 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.16226121 |
| 150 | T-helper 1 type immune response (GO:0042088) | 2.15552842 |
| 151 | detection of external biotic stimulus (GO:0098581) | 2.14924214 |
| 152 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.14769077 |
| 153 | monocyte chemotaxis (GO:0002548) | 2.14537817 |
| 154 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.14156800 |
| 155 | pentose-phosphate shunt (GO:0006098) | 2.14076682 |
| 156 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.13053073 |
| 157 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.13016088 |
| 158 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.12593063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.88174630 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.80795490 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.71661811 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.52867761 |
| 5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.08693356 |
| 6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.64780842 |
| 7 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.63513265 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.56172213 |
| 9 | * EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.55643965 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.55093056 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.53258374 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.39253495 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.31960982 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.24523642 |
| 15 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.20244191 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.18777376 |
| 17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.15678691 |
| 18 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.14156266 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.02388183 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.96202806 |
| 21 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.91857147 |
| 22 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.90923877 |
| 23 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.89416307 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88834895 |
| 25 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.77938912 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77171964 |
| 27 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.76065544 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.70698360 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.67863089 |
| 30 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.65697367 |
| 31 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.65551780 |
| 32 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.64922621 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.63548338 |
| 34 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.63301060 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.62046941 |
| 36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.58253745 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.56121493 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.55140518 |
| 39 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.54270760 |
| 40 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.54266212 |
| 41 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.52138130 |
| 42 | GATA3_26560356_Chip-Seq_TH2_Human | 1.51123965 |
| 43 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.49766333 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.44964627 |
| 45 | MYB_26560356_Chip-Seq_TH2_Human | 1.44707869 |
| 46 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.44150291 |
| 47 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.42196888 |
| 48 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41701422 |
| 49 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.39860860 |
| 50 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.39860860 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.38053530 |
| 52 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.37384766 |
| 53 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.36726609 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.35216687 |
| 55 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34624658 |
| 56 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33098814 |
| 57 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.32537232 |
| 58 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.31862297 |
| 59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30680025 |
| 60 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29870012 |
| 61 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.28286375 |
| 62 | MYB_26560356_Chip-Seq_TH1_Human | 1.27284051 |
| 63 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.26096875 |
| 64 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.25672958 |
| 65 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.25576048 |
| 66 | MAF_26560356_Chip-Seq_TH1_Human | 1.24628205 |
| 67 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24544136 |
| 68 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.24216883 |
| 69 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24116481 |
| 70 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.22306253 |
| 71 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.21082350 |
| 72 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.21080635 |
| 73 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.20264493 |
| 74 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.19783220 |
| 75 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.19010529 |
| 76 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.18439407 |
| 77 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.18400230 |
| 78 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18051076 |
| 79 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.15662230 |
| 80 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13436372 |
| 81 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12197234 |
| 82 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.11596582 |
| 83 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11257272 |
| 84 | MYC_22102868_ChIP-Seq_BL_Human | 1.11109026 |
| 85 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10157660 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10044047 |
| 87 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.09605753 |
| 88 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09138439 |
| 89 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.09051389 |
| 90 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.07778004 |
| 91 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.07718783 |
| 92 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.07385599 |
| 93 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07140155 |
| 94 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.06125158 |
| 95 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.05834542 |
| 96 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05605586 |
| 97 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05058920 |
| 98 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.04303702 |
| 99 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.04055207 |
| 100 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.02657179 |
| 101 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.02281853 |
| 102 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.01724510 |
| 103 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00767861 |
| 104 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99051750 |
| 105 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98694714 |
| 106 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98480626 |
| 107 | ATF3_27146783_Chip-Seq_COLON_Human | 0.96063678 |
| 108 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.95988990 |
| 109 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95862331 |
| 110 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95443076 |
| 111 | UTX_26944678_Chip-Seq_JUKART_Human | 0.95175197 |
| 112 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.93120633 |
| 113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91627232 |
| 114 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91311693 |
| 115 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91044192 |
| 116 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.89426767 |
| 117 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.88521935 |
| 118 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88491957 |
| 119 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88418742 |
| 120 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.87284702 |
| 121 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.87065515 |
| 122 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87037882 |
| 123 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.82222703 |
| 124 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81753686 |
| 125 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80099027 |
| 126 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79984673 |
| 127 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.79638583 |
| 128 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79581626 |
| 129 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78865867 |
| 130 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78586601 |
| 131 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.78194802 |
| 132 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.77405234 |
| 133 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71071476 |
| 134 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.69930327 |
| 135 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.69705361 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009785_altered_susceptibility_to | 3.18169019 |
| 2 | MP0003724_increased_susceptibility_to | 2.78595377 |
| 3 | MP0001835_abnormal_antigen_presentation | 2.66558936 |
| 4 | MP0003436_decreased_susceptibility_to | 2.50034044 |
| 5 | MP0006082_CNS_inflammation | 2.27021791 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.24077794 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.14957542 |
| 8 | MP0008004_abnormal_stomach_pH | 2.14264247 |
| 9 | MP0010155_abnormal_intestine_physiology | 2.12425872 |
| 10 | MP0000685_abnormal_immune_system | 2.12306875 |
| 11 | MP0005025_abnormal_response_to | 2.05288946 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 2.03200940 |
| 13 | MP0002877_abnormal_melanocyte_morpholog | 2.02426973 |
| 14 | MP0002138_abnormal_hepatobiliary_system | 2.00534246 |
| 15 | MP0003186_abnormal_redox_activity | 1.95003293 |
| 16 | MP0001853_heart_inflammation | 1.90612511 |
| 17 | MP0005000_abnormal_immune_tolerance | 1.88949608 |
| 18 | MP0005397_hematopoietic_system_phenotyp | 1.83267383 |
| 19 | MP0001545_abnormal_hematopoietic_system | 1.83267383 |
| 20 | MP0002419_abnormal_innate_immunity | 1.81609638 |
| 21 | MP0005387_immune_system_phenotype | 1.79196176 |
| 22 | MP0001790_abnormal_immune_system | 1.79196176 |
| 23 | MP0003195_calcinosis | 1.78941512 |
| 24 | MP0005671_abnormal_response_to | 1.76287789 |
| 25 | MP0006054_spinal_hemorrhage | 1.69794570 |
| 26 | MP0002006_tumorigenesis | 1.69179809 |
| 27 | MP0004947_skin_inflammation | 1.67981766 |
| 28 | MP0003075_altered_response_to | 1.65736892 |
| 29 | MP0000490_abnormal_crypts_of | 1.65457990 |
| 30 | MP0009278_abnormal_bone_marrow | 1.61731705 |
| 31 | MP0001800_abnormal_humoral_immune | 1.60185956 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.60183535 |
| 33 | MP0002723_abnormal_immune_serum | 1.58403824 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.58220230 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.56357624 |
| 36 | MP0003806_abnormal_nucleotide_metabolis | 1.56262036 |
| 37 | MP0009764_decreased_sensitivity_to | 1.56183003 |
| 38 | MP0002405_respiratory_system_inflammati | 1.55325393 |
| 39 | MP0000858_altered_metastatic_potential | 1.54465762 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.50697047 |
| 41 | MP0004808_abnormal_hematopoietic_stem | 1.48836923 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.48647657 |
| 43 | MP0001873_stomach_inflammation | 1.46436238 |
| 44 | MP0002166_altered_tumor_susceptibility | 1.43856347 |
| 45 | MP0002132_abnormal_respiratory_system | 1.43822531 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.43699244 |
| 47 | MP0004264_abnormal_extraembryonic_tissu | 1.42122618 |
| 48 | MP0003866_abnormal_defecation | 1.41861142 |
| 49 | MP0001819_abnormal_immune_cell | 1.41711465 |
| 50 | MP0002420_abnormal_adaptive_immunity | 1.39830549 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.39002075 |
| 52 | MP0008469_abnormal_protein_level | 1.38037777 |
| 53 | MP0004510_myositis | 1.37697028 |
| 54 | MP0010234_abnormal_vibrissa_follicle | 1.35787334 |
| 55 | MP0003453_abnormal_keratinocyte_physiol | 1.30227045 |
| 56 | MP0008875_abnormal_xenobiotic_pharmacok | 1.28817862 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.27176084 |
| 58 | MP0000343_altered_response_to | 1.24916499 |
| 59 | MP0002139_abnormal_hepatobiliary_system | 1.21998479 |
| 60 | MP0005023_abnormal_wound_healing | 1.20851516 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.20259631 |
| 62 | MP0002998_abnormal_bone_remodeling | 1.16634847 |
| 63 | MP0003763_abnormal_thymus_physiology | 1.15836553 |
| 64 | MP0003693_abnormal_embryo_hatching | 1.15766967 |
| 65 | * MP0002398_abnormal_bone_marrow | 1.15239626 |
| 66 | MP0008260_abnormal_autophagy | 1.12460727 |
| 67 | MP0005085_abnormal_gallbladder_physiolo | 1.10314296 |
| 68 | MP0002396_abnormal_hematopoietic_system | 1.10155822 |
| 69 | MP0003303_peritoneal_inflammation | 1.09761201 |
| 70 | MP0005360_urolithiasis | 1.09022020 |
| 71 | * MP0000716_abnormal_immune_system | 1.08993553 |
| 72 | MP0003828_pulmonary_edema | 1.05737734 |
| 73 | MP0000689_abnormal_spleen_morphology | 1.04181484 |
| 74 | MP0009840_abnormal_foam_cell | 1.03872919 |
| 75 | MP0002254_reproductive_system_inflammat | 1.03024448 |
| 76 | MP0001881_abnormal_mammary_gland | 1.01926600 |
| 77 | * MP0002429_abnormal_blood_cell | 1.01484882 |
| 78 | MP0009643_abnormal_urine_homeostasis | 1.01384591 |
| 79 | MP0003448_altered_tumor_morphology | 1.00907223 |
| 80 | MP0002722_abnormal_immune_system | 0.99513328 |
| 81 | MP0009763_increased_sensitivity_to | 0.98170915 |
| 82 | MP0005408_hypopigmentation | 0.97166624 |
| 83 | MP0005365_abnormal_bile_salt | 0.96383197 |
| 84 | MP0004782_abnormal_surfactant_physiolog | 0.95999254 |
| 85 | MP0005390_skeleton_phenotype | 0.95741814 |
| 86 | MP0003172_abnormal_lysosome_physiology | 0.94966234 |
| 87 | MP0004883_abnormal_blood_vessel | 0.93681607 |
| 88 | MP0002332_abnormal_exercise_endurance | 0.92314227 |
| 89 | MP0000477_abnormal_intestine_morphology | 0.92313506 |
| 90 | MP0005166_decreased_susceptibility_to | 0.92096569 |
| 91 | MP0005310_abnormal_salivary_gland | 0.90429081 |
| 92 | MP0002277_abnormal_respiratory_mucosa | 0.90352837 |
| 93 | MP0003252_abnormal_bile_duct | 0.89125661 |
| 94 | MP0010307_abnormal_tumor_latency | 0.87614958 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.87509788 |
| 96 | MP0000609_abnormal_liver_physiology | 0.87148503 |
| 97 | MP0003950_abnormal_plasma_membrane | 0.85819747 |
| 98 | MP0005165_increased_susceptibility_to | 0.84873768 |
| 99 | MP0003943_abnormal_hepatobiliary_system | 0.84266499 |
| 100 | MP0002019_abnormal_tumor_incidence | 0.83541868 |
| 101 | MP0005164_abnormal_response_to | 0.83474173 |
| 102 | MP0000604_amyloidosis | 0.82109488 |
| 103 | MP0009765_abnormal_xenobiotic_induced | 0.81630550 |
| 104 | MP0005076_abnormal_cell_differentiation | 0.81589196 |
| 105 | MP0003656_abnormal_erythrocyte_physiolo | 0.81583345 |
| 106 | MP0001666_abnormal_nutrient_absorption | 0.81095116 |
| 107 | MP0004957_abnormal_blastocyst_morpholog | 0.80985811 |
| 108 | MP0000627_abnormal_mammary_gland | 0.78026512 |
| 109 | MP0010368_abnormal_lymphatic_system | 0.77983199 |
| 110 | MP0004019_abnormal_vitamin_homeostasis | 0.77882905 |
| 111 | MP0003690_abnormal_glial_cell | 0.77769479 |
| 112 | MP0001851_eye_inflammation | 0.77762416 |
| 113 | MP0005319_abnormal_enzyme/_coenzyme | 0.76460780 |
| 114 | MP0008007_abnormal_cellular_replicative | 0.76117641 |
| 115 | MP0000598_abnormal_liver_morphology | 0.75297841 |
| 116 | MP0005451_abnormal_body_composition | 0.74650821 |
| 117 | MP0005167_abnormal_blood-brain_barrier | 0.74274981 |
| 118 | MP0001663_abnormal_digestive_system | 0.73276608 |
| 119 | MP0000249_abnormal_blood_vessel | 0.73161327 |
| 120 | MP0001542_abnormal_bone_strength | 0.72722586 |
| 121 | MP0002933_joint_inflammation | 0.70503821 |
| 122 | MP0003795_abnormal_bone_structure | 0.68846186 |
| 123 | MP0003091_abnormal_cell_migration | 0.63260525 |
| 124 | MP0000703_abnormal_thymus_morphology | 0.60494708 |
| 125 | MP0003045_fibrosis | 0.59255088 |
| 126 | MP0003183_abnormal_peptide_metabolism | 0.59028473 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 4.06074783 |
| 2 | Eczematoid dermatitis (HP:0000976) | 3.90209568 |
| 3 | Myositis (HP:0100614) | 3.79016424 |
| 4 | Orchitis (HP:0100796) | 3.72127293 |
| 5 | Interstitial pulmonary disease (HP:0006530) | 3.70562879 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 3.65124136 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.65124136 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.65124136 |
| 9 | Recurrent abscess formation (HP:0002722) | 3.49326240 |
| 10 | Optic neuritis (HP:0100653) | 3.42453427 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 3.42453427 |
| 12 | Pustule (HP:0200039) | 3.38630329 |
| 13 | Micronodular cirrhosis (HP:0001413) | 3.38377064 |
| 14 | Esophageal varix (HP:0002040) | 3.33890737 |
| 15 | Petechiae (HP:0000967) | 3.29278625 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.25247737 |
| 17 | Thrombocytosis (HP:0001894) | 3.20712109 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.18362071 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.18362071 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 3.16633166 |
| 21 | Loss of speech (HP:0002371) | 3.00852049 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 3.00151823 |
| 23 | Meningitis (HP:0001287) | 2.93940794 |
| 24 | Abnormality of T cell number (HP:0011839) | 2.92570176 |
| 25 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.87833991 |
| 26 | Gangrene (HP:0100758) | 2.83700697 |
| 27 | T lymphocytopenia (HP:0005403) | 2.78083870 |
| 28 | Gastrointestinal infarctions (HP:0005244) | 2.76168081 |
| 29 | Recurrent fungal infections (HP:0002841) | 2.74269123 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 2.71527305 |
| 31 | Obstructive lung disease (HP:0006536) | 2.71527305 |
| 32 | Hematochezia (HP:0002573) | 2.67943099 |
| 33 | Autoimmune thrombocytopenia (HP:0001973) | 2.67701585 |
| 34 | Amyloidosis (HP:0011034) | 2.57676965 |
| 35 | Abnormality of macrophages (HP:0004311) | 2.56336580 |
| 36 | Abnormality of T cell physiology (HP:0011840) | 2.51298330 |
| 37 | Gingival bleeding (HP:0000225) | 2.49415030 |
| 38 | Glomerulonephritis (HP:0000099) | 2.47700795 |
| 39 | IgA deficiency (HP:0002720) | 2.46340070 |
| 40 | Increased serum ferritin (HP:0003281) | 2.43677296 |
| 41 | IgM deficiency (HP:0002850) | 2.43254768 |
| 42 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.42639820 |
| 43 | Hypergammaglobulinemia (HP:0010702) | 2.42048934 |
| 44 | Anorexia (HP:0002039) | 2.40647609 |
| 45 | Vasculitis (HP:0002633) | 2.40588685 |
| 46 | Periodontitis (HP:0000704) | 2.40141006 |
| 47 | Joint swelling (HP:0001386) | 2.38914297 |
| 48 | Leukocytosis (HP:0001974) | 2.36816334 |
| 49 | Basal ganglia calcification (HP:0002135) | 2.34411003 |
| 50 | Abnormality of B cell number (HP:0010975) | 2.33682704 |
| 51 | Abnormal platelet volume (HP:0011876) | 2.32289437 |
| 52 | Pulmonary embolism (HP:0002204) | 2.32272517 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.31323556 |
| 54 | Increased cerebral lipofuscin (HP:0011813) | 2.30485478 |
| 55 | Polyneuropathy (HP:0001271) | 2.30444516 |
| 56 | Episodic fever (HP:0001954) | 2.29937124 |
| 57 | Hepatosplenomegaly (HP:0001433) | 2.28779871 |
| 58 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.27103888 |
| 59 | Abnormality of iron homeostasis (HP:0011031) | 2.27036861 |
| 60 | Arterial thrombosis (HP:0004420) | 2.26246496 |
| 61 | Increased mean platelet volume (HP:0011877) | 2.25501302 |
| 62 | Keratoconjunctivitis sicca (HP:0001097) | 2.24918189 |
| 63 | Vacuolated lymphocytes (HP:0001922) | 2.23436873 |
| 64 | Abnormality of the nasal mucosa (HP:0000433) | 2.23341422 |
| 65 | Progressive neurologic deterioration (HP:0002344) | 2.22995302 |
| 66 | Abnormal number of erythroid precursors (HP:0012131) | 2.22981578 |
| 67 | Recurrent viral infections (HP:0004429) | 2.22508227 |
| 68 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.21595928 |
| 69 | Eosinophilia (HP:0001880) | 2.21064596 |
| 70 | Disinhibition (HP:0000734) | 2.21005002 |
| 71 | Epistaxis (HP:0000421) | 2.20000216 |
| 72 | Dysostosis multiplex (HP:0000943) | 2.19493892 |
| 73 | Tetraparesis (HP:0002273) | 2.17827593 |
| 74 | Nasal polyposis (HP:0100582) | 2.16240390 |
| 75 | Keratoconjunctivitis (HP:0001096) | 2.16113210 |
| 76 | Parakeratosis (HP:0001036) | 2.13650698 |
| 77 | Premature loss of primary teeth (HP:0006323) | 2.12026344 |
| 78 | Onycholysis (HP:0001806) | 2.11993710 |
| 79 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.10932247 |
| 80 | Osteolytic defects of the hand bones (HP:0009699) | 2.10932247 |
| 81 | Peritonitis (HP:0002586) | 2.09315337 |
| 82 | Chronic otitis media (HP:0000389) | 2.07287465 |
| 83 | Malnutrition (HP:0004395) | 2.05627757 |
| 84 | Reduced antithrombin III activity (HP:0001976) | 2.04722461 |
| 85 | Vertigo (HP:0002321) | 2.03753481 |
| 86 | Abnormality of the pericardium (HP:0001697) | 2.03385968 |
| 87 | Abnormality of T cells (HP:0002843) | 2.02780767 |
| 88 | Cheilitis (HP:0100825) | 2.02666795 |
| 89 | Glomerulopathy (HP:0100820) | 2.02582471 |
| 90 | Recurrent skin infections (HP:0001581) | 2.01709160 |
| 91 | Abnormal hemoglobin (HP:0011902) | 1.99659393 |
| 92 | Chest pain (HP:0100749) | 1.98689794 |
| 93 | Panhypogammaglobulinemia (HP:0003139) | 1.98231710 |
| 94 | Complement deficiency (HP:0004431) | 1.97956302 |
| 95 | Nausea (HP:0002018) | 1.97114995 |
| 96 | Stomatitis (HP:0010280) | 1.96791105 |
| 97 | Menorrhagia (HP:0000132) | 1.96091485 |
| 98 | Reticulocytopenia (HP:0001896) | 1.96011158 |
| 99 | Pulmonary infiltrates (HP:0002113) | 1.95711111 |
| 100 | Aplastic anemia (HP:0001915) | 1.94710990 |
| 101 | Gingivitis (HP:0000230) | 1.94471280 |
| 102 | Increased IgE level (HP:0003212) | 1.94176189 |
| 103 | B lymphocytopenia (HP:0010976) | 1.93842590 |
| 104 | Chronic diarrhea (HP:0002028) | 1.92374628 |
| 105 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.91610756 |
| 106 | Colitis (HP:0002583) | 1.90621099 |
| 107 | Xerostomia (HP:0000217) | 1.89310815 |
| 108 | Thrombophlebitis (HP:0004418) | 1.89300130 |
| 109 | Recurrent bronchitis (HP:0002837) | 1.89241988 |
| 110 | Osteomyelitis (HP:0002754) | 1.88891975 |
| 111 | Prostate neoplasm (HP:0100787) | 1.88779702 |
| 112 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.87057987 |
| 113 | Skin ulcer (HP:0200042) | 1.86908912 |
| 114 | Abnormality of the intrinsic pathway (HP:0010989) | 1.86506859 |
| 115 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.85610259 |
| 116 | Increased IgM level (HP:0003496) | 1.84987469 |
| 117 | Keratitis (HP:0000491) | 1.83164333 |
| 118 | Polycythemia (HP:0001901) | 1.82725424 |
| 119 | Hemoptysis (HP:0002105) | 1.82343257 |
| 120 | Abnormal platelet function (HP:0011869) | 1.82150148 |
| 121 | Impaired platelet aggregation (HP:0003540) | 1.82150148 |
| 122 | Purpura (HP:0000979) | 1.79158826 |
| 123 | Multiple enchondromatosis (HP:0005701) | 1.78972191 |
| 124 | Abnormality of proline metabolism (HP:0010907) | 1.78282890 |
| 125 | Hydroxyprolinuria (HP:0003080) | 1.78282890 |
| 126 | Cellulitis (HP:0100658) | 1.78038541 |
| 127 | Hypoglycemic coma (HP:0001325) | 1.77100408 |
| 128 | 11 pairs of ribs (HP:0000878) | 1.76119875 |
| 129 | Encephalitis (HP:0002383) | 1.75746809 |
| 130 | Abnormality of the common coagulation pathway (HP:0010990) | 1.75551106 |
| 131 | Inflammation of the large intestine (HP:0002037) | 1.73796153 |
| 132 | Abnormality of the pleura (HP:0002103) | 1.72222753 |
| 133 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.71492171 |
| 134 | Urticaria (HP:0001025) | 1.70843204 |
| 135 | Spontaneous hematomas (HP:0007420) | 1.69627145 |
| 136 | Abnormality of the prostate (HP:0008775) | 1.69451094 |
| 137 | Myocardial infarction (HP:0001658) | 1.68653651 |
| 138 | Gastrointestinal inflammation (HP:0004386) | 1.67141704 |
| 139 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.66780998 |
| 140 | Autoimmune hemolytic anemia (HP:0001890) | 1.66071985 |
| 141 | Alveolar cell carcinoma (HP:0006519) | 1.64607363 |
| 142 | Abnormal foot bone ossification (HP:0010675) | 1.64176494 |
| 143 | Focal segmental glomerulosclerosis (HP:0000097) | 1.63832129 |
| 144 | Granulocytopenia (HP:0001913) | 1.63301207 |
| 145 | Intrahepatic cholestasis (HP:0001406) | 1.62045045 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 3.94973139 |
| 2 | MAP3K14 | 2.89497844 |
| 3 | RIPK4 | 2.81665707 |
| 4 | MST4 | 2.59925426 |
| 5 | PIM2 | 2.51640414 |
| 6 | BMPR2 | 2.45108321 |
| 7 | IRAK3 | 2.27160756 |
| 8 | TBK1 | 2.23047886 |
| 9 | BMPR1B | 2.19083240 |
| 10 | JAK3 | 2.18135673 |
| 11 | MAP4K1 | 2.16071439 |
| 12 | RPS6KB2 | 2.11796983 |
| 13 | FRK | 2.09007692 |
| 14 | NME2 | 1.89927712 |
| 15 | GRK7 | 1.88993008 |
| 16 | MAP3K3 | 1.88720749 |
| 17 | TYK2 | 1.83554015 |
| 18 | TXK | 1.76101420 |
| 19 | ERN1 | 1.75687000 |
| 20 | IRAK4 | 1.72375651 |
| 21 | STK10 | 1.68647343 |
| 22 | IKBKE | 1.65913764 |
| 23 | IKBKB | 1.64927875 |
| 24 | TGFBR1 | 1.62731226 |
| 25 | TESK1 | 1.58384041 |
| 26 | LRRK2 | 1.54853694 |
| 27 | NEK9 | 1.52112857 |
| 28 | RPS6KA4 | 1.52016063 |
| 29 | FGR | 1.49481085 |
| 30 | MAP2K3 | 1.46391061 |
| 31 | FGFR4 | 1.45606431 |
| 32 | CHUK | 1.44738488 |
| 33 | SIK3 | 1.40258179 |
| 34 | KDR | 1.38128162 |
| 35 | EIF2AK3 | 1.37871819 |
| 36 | PAK4 | 1.35715767 |
| 37 | MST1R | 1.35558742 |
| 38 | IRAK1 | 1.33640099 |
| 39 | ZAP70 | 1.31687017 |
| 40 | TEC | 1.30437822 |
| 41 | TGFBR2 | 1.29766240 |
| 42 | PTK6 | 1.28564655 |
| 43 | PIM1 | 1.26247009 |
| 44 | LMTK2 | 1.25176906 |
| 45 | JAK1 | 1.17747554 |
| 46 | MAP2K2 | 1.17164398 |
| 47 | BTK | 1.13812164 |
| 48 | TAOK2 | 1.12486758 |
| 49 | FES | 1.07821526 |
| 50 | NUAK1 | 1.07003751 |
| 51 | EPHB1 | 1.05415517 |
| 52 | BLK | 1.01948718 |
| 53 | PBK | 1.01581846 |
| 54 | TAOK3 | 0.99072428 |
| 55 | MAP3K11 | 0.98760853 |
| 56 | ACVR1B | 0.97228087 |
| 57 | EPHA3 | 0.96347284 |
| 58 | FLT3 | 0.95043990 |
| 59 | PRKG2 | 0.94474487 |
| 60 | KIT | 0.93117450 |
| 61 | CSK | 0.92171979 |
| 62 | MATK | 0.91684036 |
| 63 | PDK2 | 0.91088966 |
| 64 | NLK | 0.90864448 |
| 65 | DDR2 | 0.89590965 |
| 66 | GRK6 | 0.89071858 |
| 67 | HCK | 0.88189737 |
| 68 | PASK | 0.87561573 |
| 69 | ADRBK2 | 0.85208276 |
| 70 | CDK6 | 0.85195337 |
| 71 | CDK8 | 0.84940733 |
| 72 | ZAK | 0.80085251 |
| 73 | MAP3K8 | 0.79825258 |
| 74 | IRAK2 | 0.79502310 |
| 75 | RIPK1 | 0.79018382 |
| 76 | MAP3K12 | 0.78739724 |
| 77 | PRPF4B | 0.77039981 |
| 78 | STK24 | 0.73185433 |
| 79 | JAK2 | 0.70997483 |
| 80 | TRPM7 | 0.70545657 |
| 81 | ERBB3 | 0.69364990 |
| 82 | TIE1 | 0.69142575 |
| 83 | CLK1 | 0.68861368 |
| 84 | SCYL2 | 0.68668106 |
| 85 | MAP3K1 | 0.65682689 |
| 86 | MYLK | 0.65024606 |
| 87 | EEF2K | 0.64692110 |
| 88 | STK3 | 0.63894971 |
| 89 | EIF2AK2 | 0.63411351 |
| 90 | STK4 | 0.62265068 |
| 91 | AURKB | 0.60772311 |
| 92 | BCKDK | 0.60160205 |
| 93 | BRSK2 | 0.59451731 |
| 94 | FGFR3 | 0.59174913 |
| 95 | PKN2 | 0.58448634 |
| 96 | MAPKAPK2 | 0.58103089 |
| 97 | ITK | 0.57930427 |
| 98 | DYRK1B | 0.57160182 |
| 99 | MAP3K13 | 0.56322497 |
| 100 | OXSR1 | 0.55194567 |
| 101 | PTK2 | 0.54930177 |
| 102 | EIF2AK1 | 0.54357583 |
| 103 | MOS | 0.53412328 |
| 104 | WEE1 | 0.52532763 |
| 105 | ERBB4 | 0.51191247 |
| 106 | PIK3CG | 0.51165966 |
| 107 | HIPK2 | 0.50652663 |
| 108 | CSF1R | 0.49711561 |
| 109 | FER | 0.49396555 |
| 110 | BMX | 0.49087552 |
| 111 | CDK4 | 0.48012436 |
| 112 | YES1 | 0.46884460 |
| 113 | LCK | 0.46749149 |
| 114 | MAP3K2 | 0.45963824 |
| 115 | MARK3 | 0.45917400 |
| 116 | LYN | 0.45471025 |
| 117 | CDC42BPA | 0.45243612 |
| 118 | TAOK1 | 0.44758185 |
| 119 | MAP2K6 | 0.44479768 |
| 120 | MAP3K5 | 0.44468214 |
| 121 | VRK1 | 0.44331324 |
| 122 | CDK7 | 0.43582873 |
| 123 | MAPKAPK3 | 0.42595155 |
| 124 | LATS1 | 0.42421098 |
| 125 | TESK2 | 0.42261544 |
| 126 | DYRK3 | 0.41396220 |
| 127 | ABL2 | 0.41058349 |
| 128 | SYK | 0.39225202 |
| 129 | TRIB3 | 0.37886848 |
| 130 | ATR | 0.37699375 |
| 131 | TNK2 | 0.36812910 |
| 132 | TRIM28 | 0.36670320 |
| 133 | EGFR | 0.35099520 |
| 134 | MAPK11 | 0.35095548 |
| 135 | * ABL1 | 0.33420836 |
| 136 | PRKCQ | 0.32935773 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.05591628 |
| 2 | Legionellosis_Homo sapiens_hsa05134 | 2.35389318 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.28451976 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.18934359 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.17041704 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.12954285 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.07257845 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.88797790 |
| 9 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.81182329 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.79885325 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.79599888 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.74329801 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.73899958 |
| 14 | Pertussis_Homo sapiens_hsa05133 | 1.73434572 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.67455760 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.59070948 |
| 17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.54772198 |
| 18 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.54237566 |
| 19 | DNA replication_Homo sapiens_hsa03030 | 1.53295857 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.45885226 |
| 21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.45511866 |
| 22 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.40892209 |
| 23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.38916981 |
| 24 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36845128 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.33287916 |
| 26 | Ribosome_Homo sapiens_hsa03010 | 1.31393754 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.31336748 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.30448705 |
| 29 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.28764433 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.27637652 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.25660508 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.25499505 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.24602030 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.24489535 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.23648903 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23570677 |
| 37 | Salmonella infection_Homo sapiens_hsa05132 | 1.22887680 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.22212194 |
| 39 | Lysosome_Homo sapiens_hsa04142 | 1.21212223 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.19793686 |
| 41 | Proteasome_Homo sapiens_hsa03050 | 1.19400630 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.17854327 |
| 43 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17247927 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.17155923 |
| 45 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.14668028 |
| 46 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.13788064 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.10909257 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.09445142 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 1.09306464 |
| 50 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.06880122 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 1.05294516 |
| 52 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.04439088 |
| 53 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.03902008 |
| 54 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.03611754 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01601625 |
| 56 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.01268732 |
| 57 | Mismatch repair_Homo sapiens_hsa03430 | 1.00838736 |
| 58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99495683 |
| 59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.98180454 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.97074437 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 0.96965501 |
| 62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.95548043 |
| 63 | Galactose metabolism_Homo sapiens_hsa00052 | 0.92873480 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.92731262 |
| 65 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.92586922 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82236246 |
| 67 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.82067840 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.80935021 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80512153 |
| 70 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79601654 |
| 71 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75509522 |
| 72 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75488656 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.74932446 |
| 74 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74476719 |
| 75 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72804517 |
| 76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.72196500 |
| 77 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.70560668 |
| 78 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.69079965 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.68083391 |
| 80 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65092025 |
| 81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64947761 |
| 82 | Base excision repair_Homo sapiens_hsa03410 | 0.63451729 |
| 83 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.61337550 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60892747 |
| 85 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59935854 |
| 86 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57726699 |
| 87 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56803269 |
| 88 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.56593672 |
| 89 | Retinol metabolism_Homo sapiens_hsa00830 | 0.56447222 |
| 90 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.56037109 |
| 91 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53969087 |
| 92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.53925721 |
| 93 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53039380 |
| 94 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52481543 |
| 95 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.51426151 |
| 96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.51130916 |
| 97 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.50527884 |
| 98 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.50398281 |
| 99 | Bladder cancer_Homo sapiens_hsa05219 | 0.49899970 |
| 100 | HTLV-I infection_Homo sapiens_hsa05166 | 0.49607254 |
| 101 | Protein export_Homo sapiens_hsa03060 | 0.47206972 |
| 102 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47187131 |
| 103 | Histidine metabolism_Homo sapiens_hsa00340 | 0.45362385 |
| 104 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.44964393 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | 0.41422253 |
| 106 | Thyroid cancer_Homo sapiens_hsa05216 | 0.40662863 |
| 107 | Homologous recombination_Homo sapiens_hsa03440 | 0.39963861 |
| 108 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.39470105 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38879160 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38310317 |
| 111 | Adherens junction_Homo sapiens_hsa04520 | 0.37007429 |
| 112 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.36788152 |
| 113 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.36715329 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.36217197 |
| 115 | Platelet activation_Homo sapiens_hsa04611 | 0.35990768 |
| 116 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.34849105 |
| 117 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.33593001 |
| 118 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33214281 |
| 119 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.32930939 |
| 120 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.30314824 |
| 121 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30213395 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28714873 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.21961207 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.19742178 |
| 125 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.19339021 |
| 126 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.18567527 |
| 127 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.15903830 |
| 128 | Endocytosis_Homo sapiens_hsa04144 | 0.14860187 |
| 129 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.13748563 |
| 130 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.11920286 |
| 131 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.07580780 |
| 132 | Prion diseases_Homo sapiens_hsa05020 | 0.07012333 |
| 133 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.05628958 |

